The Bureau of Medical Services (MED) requires continued sole-source procurement of Networking Technologies, Inc.'s RxNT Electronic Prescribing of Medications, including Controlled Substance (EPMCS) Subscription Services. This justification for other than full and open competition is based on the unique qualifications of RxNT, which has spent years developing a cross-credentialing procedure essential for MED's global operations, supporting over 300 providers worldwide. The system provides critical 24/7 application support and is crucial for MED's 20,000 Foreign Service Officers and their families. Shifting to a new provider would cause significant service disruption. Although a reverse auction was conducted, no other sources could provide the required system and services, confirming RxNT as the only viable option due to its proprietary nature and unique features, including global prescription capabilities, integrated cross-credentialing, and dedicated support. The agency will continue market research to ensure future competition.